BioNTech
BNTX
320 hedge funds and large institutions have $6.02B invested in BioNTech in 2022 Q4 according to their latest regulatory filings, with 76 funds opening new positions, 103 increasing their positions, 84 reducing their positions, and 17 closing their positions.
347% more first-time investments, than exits
New positions opened: 76 | Existing positions closed: 17
23% more repeat investments, than reductions
Existing positions increased: 103 | Existing positions reduced: 84
21% more funds holding
Funds holding: 264 → 320 (+56)
20% more capital invested
Capital invested by funds: $5B → $6.02B (+$1.01B)
1.07% more ownership
Funds ownership: 15.29% → 16.35% (+1.1%)
17% less call options, than puts
Call options by funds: $349M | Put options by funds: $421M
22% less funds holding in top 10
Funds holding in top 10: 9 → 7 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$84M |
| 2 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$72.8M |
| 3 |
Capital World Investors
Los Angeles,
California
|
+$68.3M |
| 4 |
Renaissance Technologies
New York
|
+$51M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$36.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FI
Fosun International
Hong Kong,
China
|
-$103M |
| 2 |
PAMS
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
-$73.3M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$72.6M |
| 4 |
Twin Tree Management
Dallas,
Texas
|
-$38.6M |
| 5 |
AC
Armistice Capital
New York
|
-$17.9M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BRWA
326
B. Riley Wealth Advisors
Boca Raton,
Florida
| – | -$407K | -3,013 | Closed |
|
327
William Blair & Company
Chicago,
Illinois
| – | -$266K | -1,973 | Closed |
|
|
HL
328
Harding Loevner
Bridgewater,
New Jersey
| – | -$162K | -1,202 | Closed |
|
|
RF
329
Robbins Farley
Bedford,
New Hampshire
| – | -$118K | -877 | Closed |
|
|
HNB
330
Huntington National Bank
Columbus,
Ohio
| – | -$34K | -250 | Closed |
|
|
PTC
331
Private Trust Company
Cleveland,
Ohio
| – | -$12K | -90 | Closed |
|
|
GWSG
332
GPS Wealth Strategies Group
Centennial,
Colorado
| – | -$6K | -47 | Closed |
|
|
MAM
333
Meeder Asset Management
Dublin,
Ohio
| – | -$4K | -31 | Closed |
|
|
BAM
334
Byrne Asset Management
Kingston,
New Jersey
| – | -$3K | -21 | Closed |
|
|
SFG
335
Steward Financial Group
Colleyville,
Texas
| – | +$616 | +4 | New |
|
BNTX Hedge Fund Activity: Q4 2022 in Review
320 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in BioNTech (BNTX) for Q4 2022, worth a combined $6.02B — up 20% from $5B a quarter earlier.
Buyers outnumbered sellers: 76 funds opened new BNTX positions and 17 closed out — a net gain of 59 holders — while 103 added to existing stakes and 84 trimmed.
The largest buyer was BlackRock, adding an estimated $84M. The largest seller was Fosun International, exiting entirely with an estimated $103M sold.
- 320 institutional investors held BioNTech (BNTX) as of Q4 2022, up from 264 in Q3 2022.
- Funds reported $6.02B of BioNTech stock for Q4 2022, up 20% quarter-over-quarter.
- 76 funds opened new BioNTech positions in Q4 2022 and 17 closed out, a net change of +59 holders.
- The largest BioNTech buyer in Q4 2022 was BlackRock, an estimated $84M added.
- The largest BioNTech seller in Q4 2022 was Fosun International, an estimated $103M sold.
Based on aggregated 13F filings for Q4 2022.